NEOGENOMICS INC·4

Aug 3, 5:44 PM ET

Kulkarni Shashikant 4

4 · NEOGENOMICS INC · Filed Aug 3, 2022

Insider Transaction Report

Form 4
Period: 2022-08-01
Kulkarni Shashikant
President of Lab Operations
Transactions
  • Award

    Common Stock

    2022-08-01+24,70465,856 total
  • Award

    Stock Option (Right to Buy)

    2022-08-01+51,65351,653 total
    Exercise: $10.12Exp: 2029-08-01Common Stock (51,653 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $12.15Exp: 2029-04-01Common Stock (88,496 underlying)
    88,496
Footnotes (3)
  • [F1]On August 1, 2022, Dr. Kulkarni was granted 24,704 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
  • [F2]On April 1, 2022, Dr. Kulkarni was granted 88,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F3]On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

1 file
  • 4
    wf-form4_165956308168761.xmlPrimary

    FORM 4